about
Review article: biosimilars are the next generation of drugs for liver and gastrointestinal diseasesBiosimilar epoetins and other "follow-on" biologics: update on the European experiences.The evolving role of biosimilars in haematology-oncology: a practical perspective.Clinical concerns of immunogenicity produced at cellular levels by biopharmaceuticals following their parenteral administration into human body.Biosimilars: pharmacovigilance and risk management.Biosimilar recombinant human erythropoietins ("epoetins") and future erythropoiesis-stimulating treatments.Is there a reason for concern or is it just hype? - A systematic literature review of the clinical consequences of switching from originator biologics to biosimilars.Switching epoetin alfa and epoetin zeta in patients with renal anemia on dialysis: Posthoc analysis.
P2860
Q27013577-FDE2260F-B2DC-4BA0-8D36-E0ABF39CCEDAQ34131083-4E261C58-DD62-4012-96F5-1337B5C3769FQ36291259-738C8ED8-8073-4AC7-9239-84E185D85595Q37700537-20A6B40E-D1B9-46A2-8C78-C5AE1160700EQ37768112-144C3498-FC5D-4CD7-AECC-3979DF7414BCQ37999380-40A6F0F2-0A22-4613-8BEF-DF27311AC236Q38708927-20AB835D-56B3-45E6-A264-10232436AC56Q42679565-05A19672-24B1-4108-803C-E89886170CDB
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Pharmacy and pharmacology of biosimilars.
@ast
Pharmacy and pharmacology of biosimilars.
@en
type
label
Pharmacy and pharmacology of biosimilars.
@ast
Pharmacy and pharmacology of biosimilars.
@en
prefLabel
Pharmacy and pharmacology of biosimilars.
@ast
Pharmacy and pharmacology of biosimilars.
@en
P2860
P356
P1476
Pharmacy and pharmacology of biosimilars.
@en
P2093
P2860
P2888
P304
P356
10.1007/BF03346394
P577
2008-05-01T00:00:00Z
P6179
1022694956